Join us for our next Legal Answers Workshop series as experts from Ballard Spahr review 2023 life sciences developments and discuss 2024 considerations.
This program will feature topics including:
- Final 2023 merger guidelines promulgated by DOJ and FTC
- Impact of new guidelines and proposed HSR form revisions on pharma mergers
- FTC’s Proposed Ban on Non-Competes
- Enforcement Considerations for 2024
Speakers:
- Ryan Udell, Partner, and Life Sciences Industry Team Co-Leader, Ballard Sphar
- Leslie John, Partner and Practice Leader of Ballard Spahr's Antitrust and Competition Group and Co-leader of its False Advertising Litigation Team
- Jason Leckerman, Partner and Chair of the Litigation Department, Ballard Spahr
CLE Credits:
This program is approved for 1.0 in CA, NY, & PA; and 1.2 NJ. Uniform Certificates of Attendance will also be provided for the purpose of seeking credit in other jurisdictions. Any questions regarding the CLE Credits, please contact Donna Calvin, Professional Development Specialist for CLE, Ballard Spahr, at [email protected].
Agenda:
9:00am - 10:00am: Welcome & Discussion
10:00am - 10:30am: Breakout Sessions
Refunds and Questions:
- Refund/cancellation policy: This program is offered free of charge to LSPA Members in good standing. As such refunds are not applicable.
- Questions about Membership: If you are not sure you are a member or whether your membership dues are up-to-date, please contact Lois Stephens, Membership Director, [email protected]
- Questions about the Event: Contact Natalie George - [email protected]
Ballard Spahr LLP is an AmLaw 100 law firm with more than 600 attorneys in 15 US offices. We provide results-driven counsel and exceptional service in more than 50 practice areas. We are a destination practice for life sciences businesses, serving them from innovation to commercialization. Our life sciences lawyers—many of whom hold advanced degrees in the sciences—understand the complex, industry-specific issues at play. Our dedicated team includes lawyers who focus on corporate, litigation, IP and real estate matters specific to the life sciences industry.
